Abstract
THE mechanisms involved in the psychotomimetic actions of D-lysergic acid diethylamide (D-LSD) and other hallucinogenic agents have not been defined. Neurophysiological and behavioural studies indicate that D-LSD may interact with serotonin and catecholamine receptors in the central nervous system. Thus, this drug seems to stimulate certain central serotonergic pathways1,2, while inhibiting the activation of other pathways by serotonin3,4.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Anden, N.-E., Corrodi, H., Fuxe, K., and Hökfelt, T., Br. J. Pharmac., 34, 1–7 (1968).
Haigler, H. J., and Aghajanian, G. K., J. Pharmac. exp. Ther., 188, 688–699 (1974).
Boakes, R. J., Bradley, P. B., Briggs, I., and Dray, A., Br. J. Pharmac., 40, 202–218 (1970).
Kawai, N., and Yamamoto, C., Brain Res., 7, 325–328 (1968).
Bloom, F. E., in Psychopharmacology, A 10 Year Progress Report, (edit. by Effron, D. H.), 355 (United States Government Printing Office, Washington 1968).
Fog, R., Psychopharmacologia (Berl.), 14, 299–304 (1969).
Broekkamp, C. L. E., Pijnenburg, A. J. J., and van Rossum, J. M., Biochem. Pharmac., supplement (Part 2), 551–552 (1974).
Corrodi, H., Fuxe, K., Hökfelt, T., Lidbrink, P., and Ungerstedt, U., J. Pharm. Pharmac., 25, 409–412 (1973).
Johnson, A. M., Vigouret, J. M., and Loew, D. M., Experientia, 29, 763 (1973).
Stone, T. W., Brain Res., 72, 177–180 (1974).
von Hungen, K., Roberts, S., and Hill, D. F., Trans. Am. Soc. Neurochem., 5, 150 (1974).
von Hungen, K., and Roberts, S., Eur. J. Biochem., 36, 391–401 (1973).
von Hungen, K., Roberts, S., and Hill, D. F., J. Neurochem., 22, 811–819 (1974).
Krishna, G., Weiss, B., and Brodie, B. B., J. Pharmac. exp. Ther., 163, 379–385 (1968).
Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J., J. biol Chem., 193, 265–275 (1951).
Palmer, G. C., and Burks, T. F., Eur. J. Pharmac., 16, 113–116 (1971).
Kebabian, J. W., Petzold, G. L., and Greengard, P., Proc. natn. Acad. Sci. U.S.A., 69, 2145–2149 (1972).
Miller, R. J., and Iversen, L. L., Trans. Biochem. Soc., 2, 256–259 (1974).
Hornykiewicz, O., Pharmac. Rev., 18, 925–964 (1966).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
VON HUNGEN, K., ROBERTS, S. & HILL, D. LSD as an agonist and antagonist at central dopamine receptors. Nature 252, 588–589 (1974). https://doi.org/10.1038/252588a0
Received:
Issue Date:
DOI: https://doi.org/10.1038/252588a0
This article is cited by
-
LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors
Psychopharmacology (1995)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
